Alexandre Perrier
Overview
Explore the profile of Alexandre Perrier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abbar B, Labreche K, Cadranel J, Veyri M, Morin V, Thiam F, et al.
J Thorac Oncol
. 2025 Feb;
PMID: 39923848
Introduction: NSCLC is frequent and associated with poor prognosis among people living with human immunodeficiency virus (PLWHIV); nevertheless, the contributing factors remain unknown. Methods: We prospectively compared the immunogenomic characteristics...
2.
El Sissy F, Bisdorff A, Perrier A, Guillerm E, Denis J, Favre L, et al.
Mol Diagn Ther
. 2025 Feb;
PMID: 39899252
Background And Objective: Superficial vascular anomalies are complex disorders characterized by abnormal vascular growth. Next-generation sequencing has recently identified somatic genetic alterations associated with these malformations, offering new insights for...
3.
Lailler C, Didelot A, Garinet S, Berthou H, Sroussi M, De Reynies A, et al.
Oncogene
. 2024 Aug;
43(37):2781-2794.
PMID: 39147880
Patients with EGFR-mutated non-small cell lung cancer (NSCLC) benefit from treatment with tyrosine kinase inhibitors (TKI) targeting EGFR. Despite improvements in patient care, especially with the 3rd generation TKI osimertinib,...
4.
Gerasimenko A, Mignot C, Naggara O, Coulet F, Ekram S, Heide S, et al.
Clin Genet
. 2024 Feb;
106(1):90-94.
PMID: 38424388
Central nervous system (CNS) dural arteriovenous fistulas (DAVF) have been reported in PTEN-related hamartoma tumor syndrome (PHTS). However, PHTS-associated DAVF remain an underexplored field of the PHTS clinical landscape. Here,...
5.
Michaux L, Perrier A, Mehlman C, Alshehhi H, Dubois A, Lacave R, et al.
Front Oncol
. 2023 Jul;
13:1182558.
PMID: 37448514
Introduction: ALK tyrosine kinase inhibitors (ALK TKIs) have improved prognosis in -rearranged ( ) non-small-cell lung cancer (NSCLC). However, drug resistance mechanisms occur inevitably during the course of treatment leading...
6.
Roussel-Simonin C, Gougis P, Lassoued D, Vozy A, Veyri M, Morardet L, et al.
Acta Oncol
. 2023 Jun;
62(6):579-586.
PMID: 37276270
Background: Small-cell lung cancer (SCLC) accounts for approximately 15% of lung cancer and is associated with poor prognosis. In platinum-refractory or -resistant SCLC patients, few treatment options are available. Topotecan...
7.
Benusiglio P, Elder F, Touat M, Perrier A, Sanson M, Colas C, et al.
JCO Precis Oncol
. 2023 Jun;
7:e2200525.
PMID: 37262394
Purpose: The Lynch syndrome (LS)-glioma association is poorly documented. As for mismatch repair deficiency (MMRd) in glioma, a hallmark of LS-associated tumors, there are only limited data available. We determined...
8.
Pacault M, Verebi C, Champion M, Orhant L, Perrier A, Girodon E, et al.
PLoS One
. 2023 Apr;
18(4):e0280976.
PMID: 37093806
Non-invasive prenatal diagnosis of single-gene disorders (SGD-NIPD) has been widely accepted, but is mostly limited to the exclusion of either paternal or de novo mutations. Indeed, it is still difficult...
9.
Vibert R, Hasnaoui J, Perrier A, Lefebvre A, Colas C, Dhooge M, et al.
Eur J Hum Genet
. 2023 Apr;
31(9):1078-1082.
PMID: 37088804
Some patients with Lynch syndrome (LS) have extreme phenotypes, i.e. cancer before the recommended screening age, or cancer for which there are no screening guidelines. We made the hypothesis that...
10.
Mas L, Perrier A, Coulet F, Bachet J
Bull Cancer
. 2022 Dec;
109(11S):11S28-11S34.
PMID: 36535760
Advanced cholangiocarcinoma and gene fusions Cholangiocarcinomas (CCAs) are rare digestive tumors classified as intrahepatic (iCCA), perihilar (pCCA), and distal (dCCA) CCAs. These tumors are most often diagnosed at an advanced...